Dopamine receptor antagonists block nerve growth factor-induced hyperactivity

Author： Kobayashi S. Ogren S.O. Ebendal T. Olson L.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.326, Iss.1, 1997-05, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effects of dopamine D 1 and D 2 receptor antagonists on nerve growth factor protein induction

By Ozaki T.

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Comparison of the effects of dopamine D 1 and D 2 receptor antagonists on nerve growth factor mRNA expression

By Ozaki T. Mui K. Yamagami S.

European Journal of Pharmacology, Vol. 369, Iss. 1, 1999-03 ,pp. : 133-143

Elsevier

Access to resources Recommend Favorite

Effect of a 5-lipoxygenase inhibitor on nerve growth factor-induced thermal hyperalgesia in the rat

By Amann R. Schuligoi R. Lanz I. Peskar B.A.

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 89-91

Elsevier

Access to resources Recommend Favorite

Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes

By Cowell R.M. Kantor L. Hewlett G.H.K. Frey K.A. Gnegy M.E.

European Journal of Pharmacology, Vol. 389, Iss. 1, 2000-02 ,pp. : 59-65

Elsevier

Access to resources Recommend Favorite

Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism

By Ouagazzal A. Amalric M.

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite